Therapeutic algorithm for IPSS intermediate-2- and high-risk MDS patients. Shown is the strategy for treatment choices for patients with IPSS higher-risk MDS with sequential treatment in case of relapse/resistance after first-line therapy. BSC indicates best supportive care; and HSCT, hematopoietic stem cell transplant.